Intermediate for Sitagliptin. Sitagliptin ( trade name Januvia) is an orally bioavailable dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type-2 diabetes. Sitagliptin has been approved by the U.S Food and Drug Administration on Oct 17, 2006.
Product Name: Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid
CAS Number: 486460-00-8
Molecular Weight:  333.3067
Molecular Formula:  C15H18F3NO4
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.